Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS

Rochelle Wei, Arunabh Bhattacharya, Naveen Chintalaramulu, Amanda L. Jernigan, Yuhong Liu, Holly Van Remmen, Asish R. Chaudhuri

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Mutant superoxide dismutase 1 (mSOD1) is often found as aggregates at the outer-membrane of mitochondria in motor neurons of various mouse models and familial amyotrophic lateral sclerosis (f-ALS) patients. It has been postulated that disruption of mitochondrial function by physical association of misfolded mSOD1 aggregates may actually be the trigger for initiation of degeneration of motor neurons in ALS. However, it was not clear if the same mechanism is involved in muscle degeneration and mitochondrial dysfunction in skeletal muscles of ALS. Recent study from our laboratory show that two skeletal muscle proteins, namely creatine kinase (CK) and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) undergo major conformational and functional changes in the f-ALS mouse model of ALS (G93A). In this paper, we report two intriguing observations which are as follows:(i) G93A protein does not form aggregates in skeletal muscle at any stages of disease process probably due to high chymotrypsin-like activity of proteasome and thus G93A protein aggregates have no direct effects on progressive loss of muscle mass and global changes in protein conformation in ALS, and (ii) the soluble G93A protein does not have direct effects on mitochondrial dysfunction as determined by quantifying the release of reactive oxygen species (ROS) in skeletal muscle mitochondria; instead, the proteins affected by G93A possibly affect mitochondrial ROS release. These data strongly suggest for the first time that unlike in motor neurons, the soluble and aggregation states of the G93A protein do not have direct effects on protein misfolding and mitochondrial dysfunction in skeletal muscle during ALS.

Original languageEnglish (US)
Pages (from-to)1275-1279
Number of pages5
JournalBiochemical and Biophysical Research Communications
Volume417
Issue number4
DOIs
StatePublished - Jan 27 2012

Fingerprint

Mitochondrial Proteins
Superoxide Dismutase
Muscle
Skeletal Muscle
Agglomeration
Motor Neurons
Muscles
Neurons
Proteins
Mitochondria
Reactive Oxygen Species
Muscle Mitochondrion
Protein Conformation
Glyceraldehyde-3-Phosphate Dehydrogenases
Muscle Proteins
Chymotrypsin
Proteasome Endopeptidase Complex
Creatine Kinase
Conformations
Superoxide Dismutase-1

Keywords

  • ALS
  • G93A
  • Mitochondria
  • Protein misfolding
  • Reactive oxygen species

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS. / Wei, Rochelle; Bhattacharya, Arunabh; Chintalaramulu, Naveen; Jernigan, Amanda L.; Liu, Yuhong; Van Remmen, Holly; Chaudhuri, Asish R.

In: Biochemical and Biophysical Research Communications, Vol. 417, No. 4, 27.01.2012, p. 1275-1279.

Research output: Contribution to journalArticle

Wei, Rochelle ; Bhattacharya, Arunabh ; Chintalaramulu, Naveen ; Jernigan, Amanda L. ; Liu, Yuhong ; Van Remmen, Holly ; Chaudhuri, Asish R. / Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS. In: Biochemical and Biophysical Research Communications. 2012 ; Vol. 417, No. 4. pp. 1275-1279.
@article{2fa1743f296443859bc18c4d711692c0,
title = "Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS",
abstract = "Mutant superoxide dismutase 1 (mSOD1) is often found as aggregates at the outer-membrane of mitochondria in motor neurons of various mouse models and familial amyotrophic lateral sclerosis (f-ALS) patients. It has been postulated that disruption of mitochondrial function by physical association of misfolded mSOD1 aggregates may actually be the trigger for initiation of degeneration of motor neurons in ALS. However, it was not clear if the same mechanism is involved in muscle degeneration and mitochondrial dysfunction in skeletal muscles of ALS. Recent study from our laboratory show that two skeletal muscle proteins, namely creatine kinase (CK) and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) undergo major conformational and functional changes in the f-ALS mouse model of ALS (G93A). In this paper, we report two intriguing observations which are as follows:(i) G93A protein does not form aggregates in skeletal muscle at any stages of disease process probably due to high chymotrypsin-like activity of proteasome and thus G93A protein aggregates have no direct effects on progressive loss of muscle mass and global changes in protein conformation in ALS, and (ii) the soluble G93A protein does not have direct effects on mitochondrial dysfunction as determined by quantifying the release of reactive oxygen species (ROS) in skeletal muscle mitochondria; instead, the proteins affected by G93A possibly affect mitochondrial ROS release. These data strongly suggest for the first time that unlike in motor neurons, the soluble and aggregation states of the G93A protein do not have direct effects on protein misfolding and mitochondrial dysfunction in skeletal muscle during ALS.",
keywords = "ALS, G93A, Mitochondria, Protein misfolding, Reactive oxygen species",
author = "Rochelle Wei and Arunabh Bhattacharya and Naveen Chintalaramulu and Jernigan, {Amanda L.} and Yuhong Liu and {Van Remmen}, Holly and Chaudhuri, {Asish R.}",
year = "2012",
month = "1",
day = "27",
doi = "10.1016/j.bbrc.2011.12.126",
language = "English (US)",
volume = "417",
pages = "1275--1279",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Protein misfolding, mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of mSOD1 protein in skeletal muscle of ALS

AU - Wei, Rochelle

AU - Bhattacharya, Arunabh

AU - Chintalaramulu, Naveen

AU - Jernigan, Amanda L.

AU - Liu, Yuhong

AU - Van Remmen, Holly

AU - Chaudhuri, Asish R.

PY - 2012/1/27

Y1 - 2012/1/27

N2 - Mutant superoxide dismutase 1 (mSOD1) is often found as aggregates at the outer-membrane of mitochondria in motor neurons of various mouse models and familial amyotrophic lateral sclerosis (f-ALS) patients. It has been postulated that disruption of mitochondrial function by physical association of misfolded mSOD1 aggregates may actually be the trigger for initiation of degeneration of motor neurons in ALS. However, it was not clear if the same mechanism is involved in muscle degeneration and mitochondrial dysfunction in skeletal muscles of ALS. Recent study from our laboratory show that two skeletal muscle proteins, namely creatine kinase (CK) and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) undergo major conformational and functional changes in the f-ALS mouse model of ALS (G93A). In this paper, we report two intriguing observations which are as follows:(i) G93A protein does not form aggregates in skeletal muscle at any stages of disease process probably due to high chymotrypsin-like activity of proteasome and thus G93A protein aggregates have no direct effects on progressive loss of muscle mass and global changes in protein conformation in ALS, and (ii) the soluble G93A protein does not have direct effects on mitochondrial dysfunction as determined by quantifying the release of reactive oxygen species (ROS) in skeletal muscle mitochondria; instead, the proteins affected by G93A possibly affect mitochondrial ROS release. These data strongly suggest for the first time that unlike in motor neurons, the soluble and aggregation states of the G93A protein do not have direct effects on protein misfolding and mitochondrial dysfunction in skeletal muscle during ALS.

AB - Mutant superoxide dismutase 1 (mSOD1) is often found as aggregates at the outer-membrane of mitochondria in motor neurons of various mouse models and familial amyotrophic lateral sclerosis (f-ALS) patients. It has been postulated that disruption of mitochondrial function by physical association of misfolded mSOD1 aggregates may actually be the trigger for initiation of degeneration of motor neurons in ALS. However, it was not clear if the same mechanism is involved in muscle degeneration and mitochondrial dysfunction in skeletal muscles of ALS. Recent study from our laboratory show that two skeletal muscle proteins, namely creatine kinase (CK) and glyceraldehydes-3-phosphate dehydrogenase (GAPDH) undergo major conformational and functional changes in the f-ALS mouse model of ALS (G93A). In this paper, we report two intriguing observations which are as follows:(i) G93A protein does not form aggregates in skeletal muscle at any stages of disease process probably due to high chymotrypsin-like activity of proteasome and thus G93A protein aggregates have no direct effects on progressive loss of muscle mass and global changes in protein conformation in ALS, and (ii) the soluble G93A protein does not have direct effects on mitochondrial dysfunction as determined by quantifying the release of reactive oxygen species (ROS) in skeletal muscle mitochondria; instead, the proteins affected by G93A possibly affect mitochondrial ROS release. These data strongly suggest for the first time that unlike in motor neurons, the soluble and aggregation states of the G93A protein do not have direct effects on protein misfolding and mitochondrial dysfunction in skeletal muscle during ALS.

KW - ALS

KW - G93A

KW - Mitochondria

KW - Protein misfolding

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84863035837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863035837&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2011.12.126

DO - 10.1016/j.bbrc.2011.12.126

M3 - Article

C2 - 22234310

AN - SCOPUS:84863035837

VL - 417

SP - 1275

EP - 1279

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -